Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Quant Multi Cap Fund (G)
[Equity: Multi Cap]  
 
Fund Details
Fund Type Growth Launch Date 21-Mar-01
Corpus(Cr.) 7725.00 Latest NAV 629.646 As on 29-10-2026
Equity(%) 93.27 52 Week High 668.582
Debt(%) 6.73 52 Week Low 536.261
Others(%) 0.00 Exit Load 1% for redemption within 15 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark Nifty 500 Multicap 50:25:25 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Ayusha Kumbhat
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme aims at providing long term capital appreciation and generating income with a diversified portfolio of Large Cap, Mid Cap and Small Cap companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 34.72%
Top 10 Holdings 51.77%
Top 25 Holdings 81.29%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 17.95
Energy 10.74
Derivatives 8.35
Trading 4.63
Banking & Financial 4.48
Transportation 4.37
Finance & Investments 4.04
SOV 3.99
Automobile 3.89
Industrial Products 3.8
Textiles 3.78
Telecom 3.64
Consumer Durables 3.08
Cash 2.74
Construction 2.72
Media & Entertainment 2.63
Retail 2.52
Chemicals 2.44
Agricultural & Farm Machinery 2.13
Minerals & Mining 1.32
Electricals 1.28
SERVICES 1.28
Food Beverage & Tobacco 1.15
FMCG 0.87
Software & Services 0.67
Healthcare 0.59
Fertilisers 0.56
Equity MF 0.36
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.49
PE Ratio 25.13
 
Top 25 Holdings
Holdings Net Asset(%)
TREPS 01-Oct-2026 DEPO 10 11.29
Aurobindo Pharma Ltd. 9.49
Adani Power Limited 5.12
Adani Enterprises Ltd. 4.63
JSW Infrastructure Limited 4.19
Adani Green Energy Limited 3.87
Samvardhana Motherson International Limited 3.81
Zydus Lifesciences Limited 3.66
LG Electronics India Limited 3.08
SUN TV NETWORK LIMITED 2.63
NIPPON LIFE INDIA ASSET MANAGEMENT LIMITED 2.51
Swan Corp Limited 2.44
Glenmark Pharmaceuticals Ltd. 2.42
AWL AGRI BUSINESS LIMITED 2.12
STRIDES PHARMA SCIENCE LIMITED 2.12
IRB Infrastructure Developers Limited 2.10
CRISIL Ltd. 2.07
Lic Housing Finance Ltd. 1.97
K.P.R. Mill Ltd. 1.94
EMBASSY DEVELOPMENTS LIMITED 1.78
Adani Energy Solutions Limited 1.75
Bharti Airtel Ltd. 1.49
Torrent Pharmaceuticals Ltd. 1.41
ICICI Prudential Asset Management Company Limited 1.39
Divis Laboratories Ltd. 1.36

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.05% -4.65% 1.39% -0.89%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty 500 Multicap 50:25:25 TRI]
-1.35% -5.82% -2.41% -5.87%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
-2.08% 8.77% 9.19% 16.04%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
-0.30% 11.54% 10.62% 13.38%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Quant Multi Cap Fund (G) 18.17% 0.0302 130.3981% 44.4142 0.0070
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Quant Multi Cap Fund (G) 5.8226% 0.7407 0.0751 183.2336 0.0524
 
Back to Selection